Atara Biotherapeutics, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ATRA research report →
About the company
Founded in 2012 and headquartered in South San Francisco, California, Atara Biotherapeutics, Inc. is dedicated to pioneering ready-to-use (off-the-shelf) T-cell immunotherapies. Their primary focus in the United States involves creating treatments for patients battling cancer, autoimmune disorders, and viral infections.
- CEO
- Anhco Nguyen
- IPO
- 2014
- Employees
- 153
- HQ
- South San Francisco, CA, US
Price Chart
- Market Cap
- $104.97M
- P/E
- -17.65
- P/S
- 4.54
- P/B
- -4.40
- EV/EBITDA
- -19.47
- Div Yield
- 0.00%
- Gross Margin
- 96.12%
- Op Margin
- -27.27%
- Net Margin
- -40.91%
- ROE
- 25.68%
- ROIC
- -41.06%
- Revenue
- $120.77M · -6.33%
- Net Income
- $32.69M · 138.28%
- EPS
- $2.61 · 122.87%
- Op Income
- $35.86M
- FCF YoY
- 26.13%
- 52W High
- $19.14
- 52W Low
- $3.92
- 50D MA
- $8.95
- 200D MA
- $9.94
- Beta
- 0.09
- Avg Volume
- 1.42M
Get TickerSpark's AI analysis on ATRA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 11, 26 | Cherry Brian N | other | 24,000 |
| Jun 11, 26 | Cherry Brian N | other | 0 |
| Jun 9, 26 | HEIDEN WILLIAM K | other | 12,000 |
| Jun 9, 26 | Fust Matthew K | other | 12,000 |
| Jun 9, 26 | Ciongoli Gregory Austin | other | 12,000 |
| May 18, 26 | Nguyen AnhCo | sell | 5,241 |
| May 18, 26 | Grant-Huerta Yanina | sell | 2,414 |
| May 7, 26 | Panacea Innovation Ltd | sell | 313,446 |
| May 7, 26 | EcoR1 Capital, LLC | buy | 507,407 |
| May 7, 26 | EcoR1 Capital, LLC | other | 0 |
Our ATRA coverage
Recent articles, reports, and earnings notes.
No research on ATRA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ATRA report →Similar companies
Peers in the same neighborhood.